Urologists at Cleveland Clinic have found a new application for machine learning within their field, and they’re using it to improve shared decision making in the treatment of a common urologic diagnosis: overactive bladder.
30 Years Later: One of the First Patients to Have Sacral Neuromodulation for Urinary Retention Is Still Symptom-Free
Receiving the implant as part of a clinical trial in 1991, the now 81-year-old patient has been able to urinate normally with no additional treatment aside from battery changes every few years.
Is Sacral Neuromodulation a Viable Therapy After Proctectomy?
Cleveland Clinic Florida Colorectal Chairman Steven Wexner, MD, discusses sacral neuromodulation’s role in patients who have had rectal extirpation followed by neorectal reconstruction.
How Does Sacral Neuromodulation Work for Patients With Overactive Bladder?
Improving our understanding of the mechanism of action of SNM could help improve the selection of patients who might benefit from this treatment and potentially allow for improvements in the technology.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy